NEW YORK, May 9, 2011 /PRNewswire/ — Lpath, Inc. (OTC: LPTN),
the category leader in bioactive-lipid-targeted therapeutics, today
announced that their May 5th RetailInvestorConferences.com
presentation is available for on-demand viewing.
LINK: www.retailinvestorconferences.com
> Click the red “register/ watch event now” button.
Lpath, Inc.’s presentation will be available 24/7 for 90 days.
Investors may download shareholder materials from the “virtual
trade booth” for the next three weeks.
About Lpath, Inc.
San Diego-based Lpath, a therapeutic antibody company, is the
category leader in lipidomics-based therapeutics, an emerging field
of medicine that targets bioactive signaling lipids for treating a
wide range of human disease. Lpath’s ImmuneY2(TM) drug-discovery
engine has the unique ability to generate therapeutic antibodies
that bind to and inhibit bioactive lipids that contribute to
disease. The company has developed three drug candidates, two of
which — ASONEP(TM) for cancer and iSONEP(TM) for wet AMD — have
completed Phase 1 clinical trials. Lpath entered into an agreement
with Pfizer in 2010 that provides Pfizer an exclusive option for a
worldwide license to develop and commercialize iSONEP. For more
information, visit www.Lpath.com.
About RetailInvestorConferences.com:
RetailInvestorConferences.com, created by BetterInvesting
(NAIC), PR Newswire and MUNCmedia, is the first
monthly virtual investor conference series that provides an
interactive forum for presenting companies to meet directly with
retail investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based
investor conferences, Reta
‘/>”/>
SOURCE
